Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) Plans $0.25 Quarterly Dividend

Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) announced a quarterly dividend on Wednesday, January 29th,Wall Street Journal reports. Stockholders of record on Friday, February 14th will be given a dividend of 0.25 per share on Friday, February 28th. This represents a $1.00 annualized dividend and a dividend yield of 12.38%. The ex-dividend date is Friday, February 14th.

Cryo-Cell International has a payout ratio of 370.4% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments.

Cryo-Cell International Price Performance

Shares of Cryo-Cell International stock opened at $8.08 on Wednesday. Cryo-Cell International has a 1 year low of $4.47 and a 1 year high of $9.50. The company has a market cap of $65.12 million, a P/E ratio of -7.62 and a beta of 0.53.

Cryo-Cell International Company Profile

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.